HCA Healthcare has ridden a strong multi‑year run in its share price, and that puts fresh attention on a simple question for anyone looking at the stock today. Is the current valuation grounded in the cash flows that the hospital operator is generating and expected to produce, or is the market getting ahead of itself?
- Over the past 3 years, HCA Healthcare has delivered a 125.7% share price return, which raises the stakes on whether its cash generation fully underpins that climb.
- Recent news around rising uninsured admissions and facility expansion plans suggests both pressure and opportunity for future cash flows, since payer mix, funding policies and capital spending can all influence how much cash the business ultimately keeps.
- What if you looked at HCA Healthcare through its earnings instead? See what HCA Healthcare's 15.7x P/E says about the price.
The stock's next move may depend on whether investors conclude that HCA Healthcare's current price is adequately supported by the intrinsic value implied by its cash flows.
If you want to test the same cash flow question you are asking of HCA Healthcare across a broader field, compare it with companies from 35 high quality undervalued stocks.
Is HCA Healthcare Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on the cash HCA Healthcare can return to shareholders over time. On the latest figures, the group generated last twelve month free cash flow of about $6.0b, and the projections used in the model assume those cash flows keep growing rather than shrinking from that base.
Those estimates step up free cash flow into the 2030s while still discounting them back to reflect risk and time, then compare that stream with today’s share price of $510.70. The recent rise in uninsured admissions that pressured earnings helps explain why the market might hesitate to fully reflect those projected cash flows in the price, even though the DCF outputs put HCA Healthcare's estimated intrinsic value substantially above the current share price. Find out what HCA Healthcare could be worth using our Discounted Cash Flow (DCF) estimate.
The HCA Healthcare Narrative: What Would Justify Today's Price?
Narratives pick up where the DCF question leaves off and ask what story about HCA Healthcare's future cash generation, margins and earnings would need to be true for the stock to be worth meaningfully more or less than it is today on Simply Wall St's Community page. Instead of a single output from a ratio or pricing model, they lay out the future conditions that figure relies on so you can see over time whether HCA Healthcare's reality lines up with that path.
Community views on HCA Healthcare split between those who see durable strength in its model and those who think current expectations already bake that in.
Bull case: 19% undervalued
"HCA’s footprint is enormous. With hospitals, surgery centers, and outpatient facilities spread across the U.S., the company benefits from scale..."
Discover why this Narrative puts HCA Healthcare at 19% undervalued.
Bear case: 11% overvalued
"The main thing that has to go right is that HCA Healthcare continues to offset payer mix and coverage headwinds with its cost program and growing ambulatory network..."
Explore why this Narrative puts HCA Healthcare at 11% overvalued.
One more HCA Healthcare angle that can change how you see the whole story
Cash flows tell you what HCA Healthcare produces, but the people deciding where that money goes, how they are rewarded and what they are aiming for can tilt the whole risk profile. See who runs HCA Healthcare and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com